Cigna Corporation (CI) Stock

About Cigna Corporation

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.

Cigna Corporation is led by CEO David Michael Cordani, employs 71,295 people, headquartered in Bloomfield, US, publicly traded since 1982.

Cigna Corporation (CI) stock trades at $296.47 with a market capitalization of $78.43B. The stock is valued at a price-to-earnings (P/E) ratio of 12.02, price-to-book of 1.81, price-to-sales of 0.28. Over the past 52 weeks the stock has ranged between $239.51 and $350.00, and currently trades 15.3% below its 52-week high. It pays a dividend yielding 2.10%.

On profitability, Cigna Corporation generates a return on equity (ROE) of 16.27%, above the typical market average, return on capital employed of 21.80%, an operating margin of 3.32%, a net profit margin of 2.26%.

In its most recent fiscal year, Cigna Corporation reported annual revenue of $275.0B, net profit of $6.0B, revenue has compounded at 11.4% a year over the last five years, profit at -6.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.73, a current ratio of 0.85, total assets of $157.9B, $7.7B in cash and equivalents.

CI has an average daily trading volume of 1,657,863 shares, a beta of 0.30 (less volatile than the overall market).

Official website: www.thecignagroup.com